Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-043569
Filing Date
2017-07-05
Accepted
2017-07-05 18:05:50
Documents
1
Period of Report
2017-07-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10050
  Complete submission text file 0001209191-17-043569.txt   11453
Mailing Address 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015
Business Address 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015 972-725-7797
AveXis, Inc. (Issuer) CIK: 0001652923 (see all company filings)

EIN.: 901038273 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AVEXIS, INC., 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015
Business Address
Nagendran Sukumar (Reporting) CIK: 0001665124 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37693 | Film No.: 17949683